CoChat

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

Open access
Reynders, Tatjana, Devolder, Lindsay, Valles‐Colomer, Mireia, Van Remoortel, Ann, Joossens, Marie, De Keyser, Jacques, Nagels, Guy, D’hooghe, Marie, Raes, Jeroen · 2020 · Annals of Clinical and Translational Neurology
Cited by 113

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Objective: Multiple sclerosis (MS) is a heterogenous, inflammatory disease of the central nervous system. Microbiota alterations in MS versus healthy controls (HC) are observed, but results are inconsistent. We studied diversity, enterotypes, and specific gut microbial taxa variation between MS and HC, and between MS subgroups. Methods: Amplicon sequencing of the 16S ribosomal RNA V4 region (Illumina MiSeq) was used to evaluate alpha and beta diversity, enterotypes, and relative taxa abundances on stool samples. MS subgroups were based on phenotype, disease course modifiers, and treatment status. Results were controlled for recently identified confounders of microbiota composition. Results: Ninety‐eight MS patients and 120 HC were included. Microbial richness was lower in interferon‐treated (RRMS_I, N = 24) and untreated relapsing–remitting MS during relapse (RRMS_R, N = 4) when compared to benign (BMS, N = 20; Z = −3.07, P corr = 0.032 and Z = −2.68, P corr = 0.055) and primary progressive MS (PPMS, N = 26; Z = −2.39, P corr = 0.062 and Z = −2.26, P corr = 0.071). HC (N = 120) and active untreated MS (RRMS_U, N = 24) showed intermediate microbial richness. Enterotypes were associated with clinical subgroups (N = 218, χ2 = 36.10, P = 0.002), with Bacteroides 2 enterotype being more prevalent in RRMS_I. Butyricicoccus abundance was lower in PPMS than in RRMS_U (Z = −3.00, P corr = 0.014) and BMS (Z = −2.56, P corr = 0.031), lower in RRMS_I than in BMS (Z = −2.50, P corr = 0.034) and RRMS_U (Z = −2.91, P corr = 0.013), and inversely correlated with self‐reported physical symptoms (rho = −0.400, P corr = 0.001) and disease severity (rho = −0.223, P = 0.027). Interpretation: These results emphasize the importance of phenotypic subcategorization in MS‐microbiome research, possibly explaining previous result heterogeneity, while showing the potential for specific microbiome‐based biomarkers for disease activity and severity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acn3.51004

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 113

Metadata

Authors
Reynders, T., Devolder, L., Valles‐Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., Nagels, G., D’hooghe, M., & Raes, J.
Venue
Annals of Clinical and Translational Neurology
Publisher
Wiley
Published
2020-03-12
Volume
7
Issue
4
Pages
406-419
ISSN
2328-9503 (ISSN-L)
OpenAlex
W3011133899
Cited by
113
References
23
FWCI
7.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. https://app.cochat.ai/papers/10.1002/acn3.51004
The paper
Reynders, T., Devolder, L., Valles‐Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., Nagels, G., D’hooghe, M., & Raes, J. (2020). Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.